𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PCV90 THE COST-EFFECTIVENESS OF ROSUVASTATIN VERSUS SIMVASTATIN FOR THE PREVENTION OF CARDIOVASCULAR MORBIDITY AND MORTALITY IN PATIENTS WITH HIGH BASELINE RISK—A SWEDISH ECONOMIC EVALUATION BASED UPON THE JUPITER TRIAL

✍ Scribed by AG Olsson; MM Jensen; SK Gandhi; L Smolen; T Paulsson


Book ID
118614626
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
77 KB
Volume
13
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES